BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12663811)

  • 1. The processing of eIF4GI by human rhinovirus type 2 2A(pro): relationship to self-cleavage and role of zinc.
    Glaser W; Triendl A; Skern T
    J Virol; 2003 Apr; 77(8):5021-5. PubMed ID: 12663811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple eIF4GI-specific protease activities present in uninfected and poliovirus-infected cells.
    Zamora M; Marissen WE; Lloyd RE
    J Virol; 2002 Jan; 76(1):165-77. PubMed ID: 11739682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A thermosensitive mutant of HRV2 2A proteinase: evidence for direct cleavage of eIF4GI and eIF4GII.
    Liebig HD; Seipelt J; Vassilieva E; Gradi A; Kuechler E
    FEBS Lett; 2002 Jul; 523(1-3):53-7. PubMed ID: 12123803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining residues involved in human rhinovirus 2A proteinase substrate recognition.
    Sousa C; Schmid EM; Skern T
    FEBS Lett; 2006 Oct; 580(24):5713-7. PubMed ID: 17007846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human rhinovirus 2A proteinase cleavage sites in eukaryotic initiation factors (eIF) 4GI and eIF4GII are different.
    Gradi A; Svitkin YV; Sommergruber W; Imataka H; Morino S; Skern T; Sonenberg N
    J Virol; 2003 Apr; 77(8):5026-9. PubMed ID: 12663812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of 2A proteinase of human rhinovirus genetic group A with eIF4E is required for eIF4G cleavage during infection.
    Aumayr M; Schrempf A; Üzülmez Ö; Olek KM; Skern T
    Virology; 2017 Nov; 511():123-134. PubMed ID: 28843814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2A proteinase of human rhinovirus cleaves cytokeratin 8 in infected HeLa cells.
    Seipelt J; Liebig HD; Sommergruber W; Gerner C; Kuechler E
    J Biol Chem; 2000 Jun; 275(26):20084-9. PubMed ID: 10867028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human rhinovirus 2 2Apro recognition of eukaryotic initiation factor 4GI. Involvement of an exosite.
    Foeger N; Schmid EM; Skern T
    J Biol Chem; 2003 Aug; 278(35):33200-7. PubMed ID: 12791690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhinovirus 2A proteinase mediated stimulation of rhinovirus RNA translation is additive to the stimulation effected by cellular RNA binding proteins.
    Hunt SL; Skern T; Liebig HD; Kuechler E; Jackson RJ
    Virus Res; 1999 Aug; 62(2):119-28. PubMed ID: 10507322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activity of caspase inhibitors: effect on picornaviral 2A proteinase.
    Deszcz L; Seipelt J; Vassilieva E; Roetzer A; Kuechler E
    FEBS Lett; 2004 Feb; 560(1-3):51-5. PubMed ID: 14987997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and dynamics of coxsackievirus B4 2A proteinase, an enyzme involved in the etiology of heart disease.
    Baxter NJ; Roetzer A; Liebig HD; Sedelnikova SE; Hounslow AM; Skern T; Waltho JP
    J Virol; 2006 Feb; 80(3):1451-62. PubMed ID: 16415022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The eIF4G-eIF4E complex is the target for direct cleavage by the rhinovirus 2A proteinase.
    Haghighat A; Svitkin Y; Novoa I; Kuechler E; Skern T; Sonenberg N
    J Virol; 1996 Dec; 70(12):8444-50. PubMed ID: 8970966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eukaryotic initiation factor 4GII (eIF4GII), but not eIF4GI, cleavage correlates with inhibition of host cell protein synthesis after human rhinovirus infection.
    Svitkin YV; Gradi A; Imataka H; Morino S; Sonenberg N
    J Virol; 1999 Apr; 73(4):3467-72. PubMed ID: 10074204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of eukaryotic initiation factor 4G isoforms by picornaviral proteinases.
    Foeger N; Glaser W; Skern T
    J Biol Chem; 2002 Nov; 277(46):44300-9. PubMed ID: 12228254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foot-and-mouth disease virus leader proteinase: involvement of C-terminal residues in self-processing and cleavage of eIF4GI.
    Glaser W; Cencic R; Skern T
    J Biol Chem; 2001 Sep; 276(38):35473-81. PubMed ID: 11459842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct cleavage of elF4G by poliovirus 2A protease is inefficient in vitro.
    Bovee ML; Lamphear BJ; Rhoads RE; Lloyd RE
    Virology; 1998 Jun; 245(2):241-9. PubMed ID: 9636363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage of eukaryotic translation initiation factor 4GII within foot-and-mouth disease virus-infected cells: identification of the L-protease cleavage site in vitro.
    Gradi A; Foeger N; Strong R; Svitkin YV; Sonenberg N; Skern T; Belsham GJ
    J Virol; 2004 Apr; 78(7):3271-8. PubMed ID: 15016848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eukaryotic initiation factor 4GI is a poor substrate for HIV-1 proteinase.
    Schlick P; Skern T
    FEBS Lett; 2002 Oct; 529(2-3):337-40. PubMed ID: 12372624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of human rhinovirus 2A(pro) is determined by combined spatial properties of four cleavage site residues.
    Neubauer D; Aumayr M; Gösler I; Skern T
    J Gen Virol; 2013 Jul; 94(Pt 7):1535-1546. PubMed ID: 23580429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poliovirus 2A(Pro) increases viral mRNA and polysome stability coordinately in time with cleavage of eIF4G.
    Kempf BJ; Barton DJ
    J Virol; 2008 Jun; 82(12):5847-59. PubMed ID: 18400852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.